The orphaned need a friend, a real friend indeed. Amicus Therapeutics is just that friend. And the orphans in need are the rare orphan diseases that globally affect small groups of people; usually fewer than 200,000 individuals. The term ‘orphan’ opens the heart of compassion because to neglect needs based on small numbers is not something that Amicus Therapeutics is prepared to do (MarketWatch). In fact, this courageous and unique biotechnology company is a hero to the world’s forgotten warriors that fight genetic diseases that are often misdiagnosed due to the complex nature of the pathologies. These diseases include: Fabry Disease, Pompe and Epidermolysis Bullosa or EB. Amicus Therapeutics has been recognized for innovation and creativity in brokering partnerships in the industry to leverage platforms of science, technology, commercialization and manufacturing in order to successfully bring revolutionary products to the underserved and forgotten around the globe. And in doing that, Amicus Therapeutics has been awarded prestigious research grants to continue to develop miracle therapies from The Michael J. Fox Foundation and the Alzheimer’s Drug Discovery Foundation. This collaborative research is carried out at the medical groundbreaking centers of the David Geffen School of Medicine at UCLA and Icahn School of Medicine at Mount Sinai, so coast to coast Amicus Therapeutics is advancing medicine through pharmaceutical solutions. Along with these winning strategies, Amicus Therapeutics has acquired two biopharmaceutical companies, Callidus Biopharma and Scioderm in order to position the company for future success.
Thanks to Amicus Therapeutics, people who suffer from devastating diseases are not orphaned by medicine and are given real solutions that are changing lives worldwide. The stories of people struggling to thrive in life with debilitating diseases that strike multiple family members may not seem like many because they are rare; they are nonetheless at the forefront of all that the talented people at Amicus Therapeutics are passionately working to bring to the market (YahooFinance). Those people that feel orphaned are finding much needed hope in breakthroughs on the way that will heal their lives.
Follow Amicus Therapeutics on Twitter |